A New Project Could Fulfill a Promise

Just as cataloging the human genome provides a jumping-off point to develop genetic testing and molecular-based therapies, a similar effort is necessary on the cellular level. A detailed understanding of how human cells develop into specialized tissues will open the door to regenerative medicine, the therapeutic replacement of cells, tissues, and organs lost to disease. But a significant barrier to fulfilling the promise of regenerative medicine is the absence of a fully characterized, human

Written byJoseph Perpich
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Just as cataloging the human genome provides a jumping-off point to develop genetic testing and molecular-based therapies, a similar effort is necessary on the cellular level. A detailed understanding of how human cells develop into specialized tissues will open the door to regenerative medicine, the therapeutic replacement of cells, tissues, and organs lost to disease. But a significant barrier to fulfilling the promise of regenerative medicine is the absence of a fully characterized, human cell catalog.

Following on its collaboration with the Human Genome Project (HGP), the international biological community should focus on the human cell as its next strategic goal. A so-called Human Cell Project (HCP) could collect fully characterized human cell lines. This new resource--which would be unique with respect to the number and types of cells included, the degree to which these cells would be characterized, and the level of standardization at every data-collection step--would be available, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies